Promoter methylation analysis of seven clock genes in Parkinson's disease

Neuroscience Letters

Volumn 507, Issue 2, 2012, Pages 147-150

  Lin, Qingling ^a,b,c   Ding, Hui ^a,c   Zheng, Zheng ^a,c   Gu, Zhuqin ^a,c   Ma, Jinghong ^a,c   Chen, Ling ^a,c,d   Chan, Piu ^a,c   Cai, Yanning ^a,b,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Beijing Geriatric Medical Research Center   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d China International Neuroscience Institute   (China)

Author keywords

Clock genes; Parkinson's disease; Promoter methylation

Indexed keywords

ADULT; AGED; ARTICLE; BMAL1 GENE; CLOCK GENE; CONTROLLED STUDY; CPG ISLAND; CRY1 GENE; CRY2 GENE; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE SEQUENCE; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MOLECULAR CLOCK; NPAS2 GENE; PARKINSON DISEASE; PER1 GENE; PER2 GENE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION;

AGED; CLOCK PROTEINS; DNA METHYLATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS, GENETIC;

EID: 84855333470     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.12.007     Document Type: Article

References (24)

1. Baba Y., Kuroiwa A., Uitti R.J., Wszolek Z.K., Yamada T. Alterations of T-lymphocyte populations in Parkinson's disease. Parkinsonism Relat. Disord. 2005, 11:493-498.
2. Brandes J.C., Carraway H., Herman J.G. Optimal primer design using the novel primer design program: MSP primer provides accurate methylation analysis of the ATM promoter ATM is not frequently methylated in cancer. Oncogene 2007, 26:6229-6237.
3. Bredberg A., Bodmer W. Cytostatic drug treatment causes seeding of gene promoter methylation. Eur. J. Cancer. 2007, 43:947-954.
4. Bruguerolle B., Simon N. Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function. Clin. Neuropharmacol. 2002, 25:194-201.
5. Buysse D.J., Reynolds C.F., Monk T.H., Hoch C.C., Yeager A.L., Kupfer D.J. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28:193-213.
6. Cai Y., Liu S., Southern R., Xu S., Chan P. Expression of clock genes PER1 and BMAL1 in total leukocytes in health and Parkinson's disease. Eur. J. Neurol. 2010, 17:550-554.
7. Cai Y., Liu S., Sothern R.B., Li N., Guan Y., Chan P. Epigenetic analysis of mPER1 promoter in peripheral tissues. Biol. Rhythm Res. 2009, 40:445-453.
8. Dardente H., N.Cermakian Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 2007, 24:195-213.
9. Ding H., Liu S., Yuan Y.Q., Lin, Chan P., Cai Y. Decreased expression of Bmal2 in patients with Parkinson's disease. Neurosci. Lett. 2011, 499:186-188.
10. Fahn S., Elton R.L. The members of the UPDRS Development Committee, United Parkinson's Disease Rating Scale. Recent Development in Parkinson's Disease 1987, 153-163. Mac-Millan Health Care Information, Florham Park, NJ. S. Fahn, C.D. Marsden, D.B. Calne, A. Lieberman (Eds.).
11. Holliday R., Grigg G.W. DNA methylation and mutation. Mutat. Res. 1993, 285:61-67.
12. Hood S., Cassidy P., Cossette M.P., Weigl Y., Verwey M., Robinson B., Stewart J., Amir S. Endogenous dopamine regulates the rhythm of expression of the clock protein PER2 in the rat dorsal striatum via daily activation of D2 dopamine receptors. J. Neurosci. 2010, 30:14046-14058.
13. Hsu M.S., Huang C.C., Choo K.B., Huang C.J. Uncoupling of promoter methylation and expression of Period1 in cervical cancer cells. Biochem. Biophys. Res. Commun. 2007, 360:257-262.
14. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinic-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 1992, 55:181-184.
15. Ji Y., Qin Y., Shu H., Li X. Methylation analyses on promoters of mPER1, mPER2, and mCRY1 during perinatal development. Biochem. Biophys. Res. Commun 2010, 391:1742-1747.
16. Liu H.C., Hu C.J., Tang Y.C., Chang J.G. A pilot study for circadian gene disturbance in dementia patients. Neurosci. Lett. 2008, 435:229-233.
17. Monge A., Viselli F., Stocchi F., Barbato L., Bolner A., Modugno N., Paradiso M., Ruggieri S., Nordera G. Variation in the dopaminergic response during the day in Parkinson disease. Clin. Neuropharmacol. 2004, 27:116-118.
18. Parkinson J. An Essay on the Shaking Palsy 1817, Whittingham and Rowland, London.
19. Preitner N., Damiola F., Molina L.L., Zakany J., Duboule D., Albrecht U., Schibler U. The orphan nuclear receptor REV-ERB alpha controls circadian transcription within the positive limb of the mammalian circadian oscillator. Cell 2002, 110:251-260.
20. Sato T.K., Panda S., Miraglia L.J., Reyes T.M., Rudic R.D., McNamara P., Naik K.A., FitzGerald G.A., Kay S.A., Hogenesch J.B. A functional genomics strategy reveals Rora as a component of the mammalian circadian clock. Neuron 2004, 43:527-537.
21. Shih M.C., Yeh K.T., Tang K.P., Chen J.C., Chang J.G. Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR. Mol. Carcinog. 2006, 45:732-740.
22. West R.L., Lee J.M., Maroun L.E. Hypomethylation of the amyloid precursor protein gene in the brain of an Alzheimer's disease patients. J. Mol. Neurosci. 1995, 6:141-146.
23. Willis G.L. Parkinson's disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev. Neurosci. 2008, 19:245-316.
24. Zhang Z.X., Roman G.C., Hong Z., Wu C.B., Qu Q.M., Huang J.B., Zhou B., Geng Z.P., Wu J.X., Wen H.B., Zhao H., Zahner G.E. Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai. Lancet 2005, 365:595-597.